Search Results Search Sort by RelevanceMost Recent Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518. Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361. Original Research Jun 2022 لماذا نحتاج إلى رقابة أكثر صرامة على البحوث التي تشمل الأشخاصالمتأثرين بالصراع Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS AMA J Ethics. 2022;E518-529. doi: 10.1001/amajethics.2022.518. Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172. Case and Commentary Mar 2023 What Should Be Roles of Federal Clinician Governors in Motivating Equity in Locally Coordinated Triage Protocols? Isabelle M. Mikell, Courtney L. Savage Hoggard, MBE, and Harald Schmidt, PhD, MA This commentary considers how clinician-governors should respond to how Sequential Organ Failure Assessment (SOFA) scores are applied. AMA J Ethics. 2023;25(3):E179-185. doi: 10.1001/amajethics.2023.179. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.
Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518.
Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361.
Original Research Jun 2022 لماذا نحتاج إلى رقابة أكثر صرامة على البحوث التي تشمل الأشخاصالمتأثرين بالصراع Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS AMA J Ethics. 2022;E518-529. doi: 10.1001/amajethics.2022.518.
Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172.
Case and Commentary Mar 2023 What Should Be Roles of Federal Clinician Governors in Motivating Equity in Locally Coordinated Triage Protocols? Isabelle M. Mikell, Courtney L. Savage Hoggard, MBE, and Harald Schmidt, PhD, MA This commentary considers how clinician-governors should respond to how Sequential Organ Failure Assessment (SOFA) scores are applied. AMA J Ethics. 2023;25(3):E179-185. doi: 10.1001/amajethics.2023.179.